These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2843413

  • 1. [Gonadotropin-releasing hormone receptors in human breast cancer tissue].
    Kiesel L, Kaufmann M, Haeseler F, Klinga K, von Holst T, Schmidt W, Runnebaum B.
    Geburtshilfe Frauenheilkd; 1988 Jun; 48(6):420-4. PubMed ID: 2843413
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analyses.
    Mangia A, Tommasi S, Reshkin SJ, Simone G, Stea B, Schittulli F, Paradiso A.
    Oncol Rep; 2002 Jun; 9(5):1127-32. PubMed ID: 12168084
    [Abstract] [Full Text] [Related]

  • 3. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L.
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS.
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [Abstract] [Full Text] [Related]

  • 5. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [Abstract] [Full Text] [Related]

  • 6. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC.
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y, Tachibana O, Uchiyama N, Hayashi Y, Nakada M, Kita D, Watanabe T, Higashi R, Hamada J, Hayashi Y.
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [Abstract] [Full Text] [Related]

  • 8. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW, Wan DS, Wang GQ, Pan ZZ, Lu HP, Gao JH, Ding PR.
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [Abstract] [Full Text] [Related]

  • 9. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 10. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S.
    Breast Cancer Res Treat; 2005 Mar 15; 90(1):65-70. PubMed ID: 15770528
    [Abstract] [Full Text] [Related]

  • 11. Improved measurement of androgen receptors in human breast cancer.
    Lea OA, Kvinnsland S, Thorsen T.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.
    Koenders PG, Beex LV, Geurts-Moespot A, Heuvel JJ, Kienhuis CB, Benraad TJ.
    Cancer Res; 1991 Sep 01; 51(17):4544-8. PubMed ID: 1873798
    [Abstract] [Full Text] [Related]

  • 13. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G, Wittliff JL, Schally AV.
    Cancer Res; 1995 Jan 15; 55(2):280-7. PubMed ID: 7812958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH, Buchmann J.
    Zentralbl Gynakol; 2000 Jan 15; 122(2):92-5. PubMed ID: 10721188
    [Abstract] [Full Text] [Related]

  • 17. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 18. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
    Broom RJ, Tang PA, Simmons C, Bordeleau L, Mulligan AM, O'Malley FP, Miller N, Andrulis IL, Brenner DM, Clemons MJ.
    Anticancer Res; 2009 May 01; 29(5):1557-62. PubMed ID: 19443366
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA, Cnaan A.
    Arch Pathol Lab Med; 1996 Oct 01; 120(10):970-3. PubMed ID: 12046611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.